Skip to content

Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty

Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03408483
Enrollment
80
Registered
2018-01-24
Start date
2018-04-01
Completion date
2020-08-22
Last updated
2021-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Arthroplasty

Keywords

Quadratus Lumborum Block

Brief summary

Peripheral nerve blocks for joint and extremity surgeries have long been proven to provide effective post-operative analgesia. Of these surgeries, total hip arthroplasty (THA) remains one of the most common orthopedic procedures in the United States with approximately 300,000 operations performed annually. At our institution, post-operative analgesia in these patients is primarily provided through parenteral and oral opioid medications. Quadratus lumborum blocks (QLB) have been described and implemented for various surgical procedures including caesarean and laparoscopic ovarian surgery. Recently, there has been increasing interest in the efficacy of quadratus lumborum blocks for THA. Currently, case reports have established a precedent regarding the efficacy of the QLB for THA in providing superior analgesia and decreasing visual analog pain scores (VAS), but randomized trials are still lacking. The goal of this study is to compare pain scores (VAS), opioid consumption, physical therapy scores, and patient and surgeon satisfaction in patients that receive QLB versus no peripheral nerve blockade in patients undergoing THA. The results of this study have the potential to change standard of care for patients undergoing THA.

Detailed description

Currently, regional anesthesia techniques for total hip arthroplasty are limited. Fascia iliac blocks have been employed to provide analgesia for hip surgeries with blockade of the femoral, lateral femoral cutaneous, and obturator nerves via injection of local anesthetic in the iliacus fascia. In addition, lumbar plexus blocks have also been employed for post-operative analgesia, but the complexity of the block is high, and complications including epidural anesthesia are not infrequent. The quadratus lumborum block is an abdominal truncal block in which local anesthetic is deposited into the thoracolumbar fascia or the quadratus lumborum muscle itself with the goal of providing analgesia to the ipsilateral T6 - L1 sensory dermatomes. It has already been demonstrated to provide effective post-operative analgesia for certain abdominal and pelvic surgeries, but its use in total hip arthroplasty is limited to case reports. The block is accomplished by identifying the quadratus lumborum muscle, which originates from iliac crest and iliolumbar ligament, and inserted on transverse processes of upper four lumbar vertebrae and posterior border of the 12th rib. Local anesthetic is then deposited at the anterior, posterior or middle thoracolumbar fascia, or intramuscularly, depending on the technique used. Cadaveric studies8 have demonstrated dye spread to the lumbar nerve roots and nerves within the transversus abdominis plane (TAP). Carney et al9 described a posterior TAP block, now known to be synonymous with QLB, that demonstrated contrast spread to the thoracic paravertebral space from T5-L1. Case reports have described analgesia in the corresponding sensory dermatomes after QLB4, and have demonstrated efficacy in patient undergoing THA. The QLB block has potential to cover lateral femoral cutaneous nerve, femoral nerve, obturator nerve and portions of lumbar plexus. This study has been designed to investigate the efficacy of the quadratus lumborum block as a primary method of providing post-operative analgesia in patients undergoing THA. Previous trials have demonstrated the effectiveness of the block for abdominal and pelvic surgeries, and case reports have shown its applicability in hip arthroplasty. In this randomized controlled study we aim to compare QLB (intervention) with control (no intervention) group in patients undergoing THA with regard to the VAS pain scores (at PACU arrival & discharge12, 24 & 36 hours), duration of analgesia, time to first opioid medication, physical therapy evaluations, time to discharge, and surgeon and patient satisfaction scores.

Interventions

Under ultrasound guidance, the needle will be advanced to the posterior border of the quadratus lumborum muscle. After negative aspiration, a bolus of 40 mL of 0.25% bupivacaine with 1:400,000 epinephrine will be injected in 5 mL aliquots, ensuring proper placement of needle tip and appropriate spread of local anesthetic.

DRUGStandard of Care

This is currently the standard of care, no local anesthetic will be injected. Pain will be managed with parenteral and oral medication.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

In this randomized controlled study we aim to compare QLB (intervention) with control (no intervention) group in patients undergoing THA with regard to the VAS pain scores (at PACU arrival & dischage,12, 24 & 36 hours), duration of analgesia, time to first opioid medication, physical therapy evaluations, time to discharge, and surgeon and patient satisfaction scores.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients undergoing total hip arthroplasty 2. Adults 18 years of age and older 3. Patients with an American Society of Anesthesiology (ASA) physical status classification of I, II or III

Exclusion criteria

1. Patients with ASA physical status classification other than I, II, or III 2. Patients with allergies/intolerances to local anesthetic 3. Patients with pre-existing neurologic or anatomic deficits in the lower extremity on the side of the surgical site 4. Patients with coexisting coagulopathy 5. Patients that are pharmacologically anticoagulated will be excluded if placement of peripheral nerve block would be contraindicated according to ASRA (American Society for Regional Anesthesia) guidelines or if spinal anesthesia would be contraindicated according to guidelines

Design outcomes

Primary

MeasureTime frameDescription
Pain Scores Using Visual Analog Scale (VAS) ScoresAssessed between immediately postoperatively to 12 hours postoperativelyThe Visual Analogue Scale (VAS) is a psychometric response scale which is used in surveys/questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older: Rating - Pain Level 0 - No Pain 1-3 - Mild Pain (nagging, annoying, interfering little with \*ADLs) 4-6 - Moderate Pain (interferes significantly with ADLs) 7-10 - Severe Pain (disabling; unable to perform ADLs) \*ADL=Activities of Daily Living
Opioid Consumption (Oral Morphine Equivalents)from 24 hours to 48 hours postoperativelyTotal oral morphine equivalent consumption calculated

Secondary

MeasureTime frameDescription
Patient Satisfaction24 hoursPatient Satisfaction Score: Determined by patient interview conducted at the 24 hour Time Frame. The interview follows a script requesting current pain level based on a scale of 1-10: 1 = very not satisfied 10 = very satisfied Patient satisfaction is subjective.
Hours to Hospital DischargeMaximum 96 HoursFrom time of the surgical procedure to the time of hospital discharge (measured in hours) up to 3 hours.
Distance Ambulated48 hoursPhysical therapist documentation of ambulation distance measured in feet

Countries

United States

Participant flow

Participants by arm

ArmCount
Quadratus Lumborum Block (QLB)
* Patients will be placed in the lateral decubitus position w/non-operative side recumbent. Pillow or blankets will be placed btw patient's lower extremities. Standard noninvasive monitors applied, and oxygen administered via nasal cannula. Parenteral midazolam and fentanyl titrated to patient comfort. * Standard skin sterilization, prepping and draping will be applied to the area. Under ultrasound guidance, needle will be advanced to anterior border of quadratus lumborum muscle. After negative aspiration, a bolus of 30 mL of 0.25% bupivacaine with 1:400,000 epinephrine will be injected in 5 mL aliquots. * After QLB is placed, patients will have THA under spinal anesthesia.
36
Standard of Care
* Patients will be placed in the lateral decubitus position with non-operative side recumbent. A pillow or blankets placed between patient's lower extremities. Standard noninvasive monitors applied, and oxygen administered via nasal cannula. Parenteral midazolam and fentanyl titrated to patient comfort. * Standard skin sterilization, prepping and draping applied to the area. Ultrasound probe used to identify quadratus lumborum muscle. No local anesthetic injected. Standard of Care: This is currently the standard of care, no local anesthetic will be injected. Pain will be managed with parenteral and oral medication.
35
Total71

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up30
Overall StudyPhysician Decision33

Baseline characteristics

CharacteristicQuadratus Lumborum Block (QLB)TotalStandard of Care
Age, Continuous58.61 years
STANDARD_DEVIATION 2.74
58.305 years
STANDARD_DEVIATION 2.4
58.00 years
STANDARD_DEVIATION 2.06
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
17 Participants34 Participants17 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
19 Participants37 Participants18 Participants
Region of Enrollment
United States
36 participants71 participants35 participants
Sex: Female, Male
Female
20 Participants35 Participants15 Participants
Sex: Female, Male
Male
16 Participants36 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 350 / 36
other
Total, other adverse events
0 / 350 / 36
serious
Total, serious adverse events
0 / 350 / 36

Outcome results

Primary

Opioid Consumption (Oral Morphine Equivalents)

Total oral morphine equivalent consumption calculated

Time frame: immediately postoperatively to 24 hours postoperatively

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Opioid Consumption (Oral Morphine Equivalents)30.05 mg of morphine equivalentsStandard Error 3.8
Standard of CareOpioid Consumption (Oral Morphine Equivalents)47.14 mg of morphine equivalentsStandard Error 4.72
Primary

Opioid Consumption (Oral Morphine Equivalents)

Total oral morphine equivalent consumption calculated

Time frame: immediately postoperatively to 48 hours postoperatively

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Opioid Consumption (Oral Morphine Equivalents)54.63 mg of morphine equivalentsStandard Error 8.25
Standard of CareOpioid Consumption (Oral Morphine Equivalents)90.76 mg of morphine equivalentsStandard Error 10.65
Primary

Opioid Consumption (Oral Morphine Equivalents)

Total oral morphine equivalent consumption calculated

Time frame: from 24 hours to 48 hours postoperatively

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Opioid Consumption (Oral Morphine Equivalents)24.26 mg of morphine equivalentsStandard Error 4.48
Standard of CareOpioid Consumption (Oral Morphine Equivalents)40.52 mg of morphine equivalentsStandard Error 6.31
Primary

Pain Scores Using Visual Analog Scale (VAS) Scores

The Visual Analogue Scale (VAS) is a psychometric response scale which is used in surveys/questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older: Rating - Pain Level 0 - No Pain 1-3 - Mild Pain (nagging, annoying, interfering little with \*ADLs) 4-6 - Moderate Pain (interferes significantly with ADLs) 7-10 - Severe Pain (disabling; unable to perform ADLs) \*ADL=Activities of Daily Living

Time frame: Immediately postoperatively to 12 hours postoperatively

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Pain Scores Using Visual Analog Scale (VAS) Scores2.34 score on a scaleStandard Error 0.46
Standard of CarePain Scores Using Visual Analog Scale (VAS) Scores3.33 score on a scaleStandard Error 0.56
Primary

Pain Scores Using Visual Analog Scale (VAS) Scores

The Visual Analogue Scale (VAS) is a psychometric response scale which is used in surveys/questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older: Rating - Pain Level 0 - No Pain 1-3 - Mild Pain (nagging, annoying, interfering little with \*ADLs) 4-6 - Moderate Pain (interferes significantly with ADLs) 7-10 - Severe Pain (disabling; unable to perform ADLs) \*ADL=Activities of Daily Living

Time frame: Assessed between immediately postoperatively to 12 hours postoperatively

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Pain Scores Using Visual Analog Scale (VAS) Scores2.34 units on a scaleStandard Error 0.46
Standard of CarePain Scores Using Visual Analog Scale (VAS) Scores3.33 units on a scaleStandard Error 0.56
Primary

Pain Scores Using Visual Analog Scale (VAS) Scores

The Visual Analogue Scale (VAS) is a psychometric response scale which is used in surveys/questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older: Rating - Pain Level 0 - No Pain 1-3 - Mild Pain (nagging, annoying, interfering little with \*ADLs) 4-6 - Moderate Pain (interferes significantly with ADLs) 7-10 - Severe Pain (disabling; unable to perform ADLs) \*ADL=Activities of Daily Living

Time frame: Assessed between immediately postoperatively to 24 hours postoperatively

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Pain Scores Using Visual Analog Scale (VAS) Scores2.31 units on a scaleStandard Error 0.37
Standard of CarePain Scores Using Visual Analog Scale (VAS) Scores4.06 units on a scaleStandard Error 0.42
Primary

Pain Scores Using Visual Analog Scale (VAS) Scores

The Visual Analogue Scale (VAS) is a psychometric response scale which is used in surveys/questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older: Rating - Pain Level 0 - No Pain 1-3 - Mild Pain (nagging, annoying, interfering little with \*ADLs) 4-6 - Moderate Pain (interferes significantly with ADLs) 7-10 - Severe Pain (disabling; unable to perform ADLs) \*ADL=Activities of Daily Living

Time frame: Assessed between immediately postoperatively to 48 hours postoperatively

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Pain Scores Using Visual Analog Scale (VAS) Scores3.33 units on a scaleStandard Error 0.43
Standard of CarePain Scores Using Visual Analog Scale (VAS) Scores4.11 units on a scaleStandard Error 0.64
Secondary

Distance Ambulated

Physical therapist documentation of ambulation distance measured in feet

Time frame: 48 hours

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Distance Ambulated127.75 feetStandard Error 17.33
Standard of CareDistance Ambulated106.69 feetStandard Error 23.37
Secondary

Distance Ambulated

Physical therapist documentation of ambulation distance measured in feet

Time frame: 24 hours

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Distance Ambulated114.51 feetStandard Error 10.39
Standard of CareDistance Ambulated100.85 feetStandard Error 10.6
Secondary

Hours to Hospital Discharge

From time of the surgical procedure to the time of hospital discharge (measured in hours) up to 3 hours.

Time frame: Maximum 96 Hours

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Hours to Hospital Discharge53.17 hoursStandard Error 4.99
Standard of CareHours to Hospital Discharge55.97 hoursStandard Error 3.78
Secondary

Patient Satisfaction

Patient Satisfaction Score: Determined by patient interview conducted at the 24 hour Time Frame. The interview follows a script requesting current pain level based on a scale of 1-10: 1 = very not satisfied 10 = very satisfied Patient satisfaction is subjective.

Time frame: 24 hours

Population: Three patients in each group were excluded for failed spinal anesthesia. Three patients were excluded in the QLB group for missing data due to early discharge.

ArmMeasureValue (MEAN)Dispersion
Quadratus Lumborum Block (QLB)Patient Satisfaction9.14 score on a scaleStandard Error 0.28
Standard of CarePatient Satisfaction7.46 score on a scaleStandard Error 0.41

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026